Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$88,000.00

High-throughput sperm motility assay and automated selection for clinical in vitro fertilization

FY 2012-13

Summary
This proposal describes the development and application of a high-throughput sperm physiological motility measurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate the tendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screen candidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterative segments of device development, initial testing, and human sperm based testing, followed by implementation at the OVO Fertility Clinic. In Canada, one in six couples experience fertility issues and each year an estimated 3500 live births involve assisted reproductive technologies, most notably IVF. Current techniques of semen processing and sperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques may be ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, including the sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk of pregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for a clinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNA damage while reflecting as much as possible the natural in vivo process. This project is a new collaboration enabled through the CHRP opportunity. The project brings together engineering and male and female fertility health researchers, and IVF treatment providers at the OVO Fertility Clinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human sperm motility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of these findings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercialization opportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills needed to develop next-generation fertility treatments.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
399337-2011
Name nom
Sinton, David
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
88000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
3
Application title
High-throughput sperm motility assay and automated selection for clinical in vitro fertilization
Keyword
NSERC
Application summary
This proposal describes the development and application of a high-throughput sperm physiological motility measurement to: (1) quantify the correlation between sperm motility and DNA integrity; (2) correlate the tendency of sperm to swim near vessel walls with sperm viability; and (3) apply these findings to screen candidate sperm for the clinical application of in vitro fertilization (IVF). The project contains three iterative segments of device development, initial testing, and human sperm based testing, followed by implementation at the OVO Fertility Clinic. In Canada, one in six couples experience fertility issues and each year an estimated 3500 live births involve assisted reproductive technologies, most notably IVF. Current techniques of semen processing and sperm selection are crude and differ greatly from the natural process in vivo. Moreover, these techniques may be ineffective in selecting the best spermatozoa and, may result in iatrogenic damage to the sperm, including the sperm DNA. Sperm DNA damage is associated with reduced IVF pregnancy rates, increased risk of pregnancy loss after IVF, and compromised health of offspring. This project addresses the critical need for a clinically-viable, sperm selection method that avoids technician error, cell trauma, oxidative stress, and DNA damage while reflecting as much as possible the natural in vivo process. This project is a new collaboration enabled through the CHRP opportunity. The project brings together engineering and male and female fertility health researchers, and IVF treatment providers at the OVO Fertility Clinic. This work will lead to: (1) a new understanding of the fundamental characteristics of human sperm motility; (2) sperm transport modes and metrics as indicators of sperm viability; (3) the application of these findings at the clinical-level to the benefit of infertile couples and offspring; (4) new commercialization opportunities for Canadian industry; and (5) highly qualified personnel with the multidisciplinary skills needed to develop next-generation fertility treatments.